Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents

MeSH terms

• Aged
• Amyloidosis / drug therapy*
• Amyloidosis / etiology
• Amyloidosis / pathology
• Antibodies, Antinuclear / blood
• Antirheumatic Agents / therapeutic use*
• Arthritis, Rheumatoid / complications*
• Benzimidazoles / therapeutic use
• Biphenyl Compounds
• Carbazoles / therapeutic use
• Carvedilol
• Drug Therapy, Combination
• Dyspnea / diagnosis
• Dyspnea / drug therapy
• Etanercept
• Female
• Furosemide / therapeutic use
• Glucocorticoids / therapeutic use
• Hand / diagnostic imaging
• Heart Failure / drug therapy*
• Heart Failure / etiology
• Heart Failure / pathology
• Humans
• Immunoglobulin G / therapeutic use*
• Lung Diseases, Interstitial / diagnosis
• Lung Diseases, Interstitial / diagnostic imaging
• Natriuretic Peptide, Brain / blood
• Propanolamines / therapeutic use
• Radiography
• Receptors, Tumor Necrosis Factor / therapeutic use*
• Rheumatoid Factor / blood
• Ribonucleosides / therapeutic use
• Scleroderma, Systemic / complications*
• Spironolactone / therapeutic use
• Sulfasalazine / therapeutic use
• Tetrazoles / therapeutic use
• Treatment Outcome